Literature DB >> 16865775

Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma.

Jongkonnee Thanasai1, Temduang Limpaiboon, Patcharee Jearanaikoon, Vajarabhongsa Bhudhisawasdi, Narong Khuntikeo, Banchob Sripa, Masanao Miwa.   

Abstract

AIM: To analyze the DNA copy number of target genes NF2, TIMP3, ST13, TOB2, BIK, and TP and the reference microsatellite markers D22S283, D22S423, and D22S274 mapped on 22q12-qter in liver fluke related cholangiocarcinoma (CCA) and define its correlation with clinical parameters.
METHODS: Quantitative real time PCR (qPCR) was used for determining allelic imbalances in 65 liver fluke related CCA tissues. Statistical correlations between allelic imbalances and clinicopathological parameters, i.e. age, sex, tumor stage, histological type, blood vessel invasion, nerve invasion and lymphatic invasion were evaluated by means of the chi2 test. Cox regression analysis was used for determining patient's survival.
RESULTS: Amplifications of the TP (22q13.33), TOB2 (22q13.2-13.31), D22S283 (22q12.3), TIMP3 (22q12.3) and NF2 (22q12.2) were found in 35 (53.8%), 28 (43.1%), 27 (41.5%), 24 (36.9%), and 24 (36.9%), respectively. Losses at the D22S423 (22q13.1-13.2) and BIK (22q13.31) were detected in 26 (40%) and 23 (35.4%), respectively. Significant correlations were observed between lymphatic invasion and allelic losses of BIK (P = 0.025) and D22S283 (P = 0.041). Univariate and multivariate Cox regression analysis revealed D22S283 amplification as an independent predictor of good prognosis (P = 0.006, death hazard ratio = 0.411, 95% CI = 0.217-0.779) and blood vessel invasion as an independent poor prognostic factor (P = 0.042, death hazard ratio = 1.911, 95% CI = 1.022-3.571) in CCA patients.
CONCLUSION: This study provides evidence for the involvement of gene amplification and deletion on chromosome 22q in liver fluke related CCA. This is the first report of D22S283 amplification as an independent indicator of favorable prognosis in liver fluke related CCA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865775      PMCID: PMC4087744          DOI: 10.3748/wjg.v12.i27.4338

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer.

Authors:  A Hirano; M Emi; M Tsuneizumi; Y Utada; M Yoshimoto; F Kasumi; F Akiyama; G Sakamoto; S Haga; T Kajiwara; Y Nakamura
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

2.  Intrahepatic cholangiocarcinoma in Thailand.

Authors:  T Uttaravichien; V Bhudhisawasdi; C Pairojkul; A Pugkhem
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

3.  Genetic aberrations detected by comparative genomic hybridization in biliary tract cancers.

Authors:  K Shiraishi; N Kusano; S Okita; A Oga; K Okita; K Sasaki
Journal:  Oncology       Date:  1999-07       Impact factor: 2.935

4.  Comprehensive allelotyping of human intrahepatic cholangiocarcinoma.

Authors:  H Momoi; H Okabe; T Kamikawa; S Satoh; I Ikai; M Yamamoto; A Nakagawara; Y Shimahara; Y Yamaoka; M Fukumoto
Journal:  Clin Cancer Res       Date:  2001-09       Impact factor: 12.531

5.  Cancer control in Thailand.

Authors:  Vanchai Vatanasapt; Supannee Sriamporn; Patravoot Vatanasapt
Journal:  Jpn J Clin Oncol       Date:  2002-03       Impact factor: 3.019

6.  The role of thymidine phosphorylase and thrombospondin-1 in angiogenesis and progression of intrahepatic cholangiocarcinoma.

Authors:  Shin-ichi Aishima; Ken-ichi Taguchi; Keishi Sugimachi; Yoshiki Asayama; Hidehiro Nishi; Mitsuo Shimada; Keizo Sugimachi; Masazumi Tsuneyoshi
Journal:  Int J Surg Pathol       Date:  2002-01       Impact factor: 1.271

7.  Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini).

Authors:  H Ohshima; T Y Bandaletova; I Brouet; H Bartsch; G Kirby; F Ogunbiyi; V Vatanasapt; V Pipitgool
Journal:  Carcinogenesis       Date:  1994-02       Impact factor: 4.944

8.  Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis.

Authors:  M R Haswell-Elkins; S Satarug; M Tsuda; E Mairiang; H Esumi; P Sithithaworn; P Mairiang; M Saitoh; P Yongvanit; D B Elkins
Journal:  Mutat Res       Date:  1994-03-01       Impact factor: 2.433

Review 9.  The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.

Authors:  Shin-ichi Akiyama; Tatsuhiko Furukawa; Tomoyuki Sumizawa; Yuji Takebayashi; Yuichi Nakajima; Shunji Shimaoka; Misako Haraguchi
Journal:  Cancer Sci       Date:  2004-11       Impact factor: 6.716

10.  Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.

Authors:  P Englefield; W D Foulkes; I G Campbell
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more
  3 in total

1.  Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.

Authors:  Siobhan C McKay; Kristian Unger; Stephanos Pericleous; Gordon Stamp; Gerry Thomas; Robert R Hutchins; Duncan R C Spalding
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

2.  Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma.

Authors:  Jongkonnee Thanasai; Temduang Limpaiboon; Patcharee Jearanaikoon; Banchob Sripa; Chawalit Pairojkul; Srisurang Tantimavanich; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 3.  Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand.

Authors:  Masanao Miwa; Satoshi Honjo; Gyokukou You; Masakazu Tanaka; Kazuhiko Uchida; Petcharin Srivatanakul; Thiravud Khuhaprema; Watcharin Loilome; Anchalee Techasen; Chaisiri Wongkham; Temduang Limpaiboon; Puangrat Yongvanit; Sopit Wongkham
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.